U.S. Dominates Global MASH Therapy Landscape with 43% Market Share

bir ses eklendi Health

2025-06-30 10:41:33

The North America Metabolic Dysfunction–Associated Steatohepatitis (MASH) Treatment Market is witnessing exponential growth, rising from USD 3.70 billion in 2024 to an anticipated USD 17.15 billion by 2033, at a strong compound annual growth rate (CAGR) of 19.3% from 2025 to 2033. This dynamic expansion is fueled by the increasing prevalence of obesity, Type 2 diabetes, aging population,...

0 Yorumlar 0 hisse senetleri 978 Views 0 önizleme